 |
||||||
|
||||||
 |
|
Sponsored by The American Federation for Medical Research Translational Physiology |
|||||||||||||||||||||||||||||
|
Sunday, April 29 — 10:30 AM-12:30 PM Washington, DC Convention Center — Room 146B |
|
| Chaired: |
Mike Hart, Emory Univ. and Atlanta VA Med. Ctr. |
Peroxisome proliferator-activated receptors (PPARs) are members of the nuclear hormone receptor superfamily of ligand-activated transcription factors. Emerging evidence indicates that PPAR gamma (PPARg) regulates gene expression and function within several cellular compartments of the lung. This symposium will emphasize the therapeutic implications of these findings for seemingly diverse types of lung disease and clarify current understanding of the basic molecular and biochemical mechanisms by which PPARg participates in lung cell biology.
|
10:30 AM |
PPARg in the pathogenesis of lung cancer: implications for therapy. |
|
11:00 AM |
The immunomodulatory role of PPARg in alveolar macrophages. |
|
11:30 AM |
The anti-fibrogenic potential of PPARg ligands in pulmonary
fibrosis. |
|
12:00 PM |
The role of PPARg
in pulmonary vascular disease. |